Skip to main content
. Author manuscript; available in PMC: 2019 Dec 6.
Published in final edited form as: Bone Marrow Transplant. 2019 May 31;54(12):1995–2003. doi: 10.1038/s41409-019-0573-6

Table 1. Summary data of bone marrow harvests for GT. Data indicate median and range.

^data available for the last consecutive 8 ADA SCID patients.

Disease Age at GT (years) Weight (kg) Harvested volume (ml) Volume/kg Collected TNC (x108)/kg CD34+ (%) Collected CD34+ cells (x106)/kg Selected CD34+ cells (x106)/kg Infused CD34+ cells (x106)/kg
ADA SCID
(n=23)
1.7
(0.5-6.0)
10.1
(5.9-26.5)
303.0
(190.0-1167.5)
31.2
(14.2-48.6)
4.2
(2.9-6.8)
5.7
(2.0-6.7)^
28.9
(9.8-43.1)^
13.8
(4.4-22.9)
10.7
(3.7-19.7)
WAS
(n=6)
2.1
(0.9-6.0)
12.7
(8.0-26.3)
424.3
(275.0-773.0)
34.2
(29.4-36.5)
5.7
(3.5-6.6)
2.9
(1.8-5.2)
15.8
(10.8-18.7)
9.1
(4.5-14.5)
9.0
(3.7-14.1)
MLD
(n=28)
1.3
(0.5-11.4)
11
(7.3-25.3)
420.0
(194.0-1132.0)
36.9
(17.6-56.6)
6.3
(3.4-9.4)
3.0
(1.0-7.7)
16.3
(5.6-65.9)
9.6
(3.9-34.7)
10.3
(3.8-25.9)
Total
(n=57)
1.5
(0.5-11.4)
10.6
(5.9-26.5)
348.0
(190.0-1167.5)
34.2
(14.2-56.6)
5.1
(2.9-9.4)
3.1
(1.0-7.7)
17.3
(5.6-65.9)
10.4
(3.9-34.7)
10.3
(3.7-25.9)